↑ Rising
Business
French biotech stock soars 34% after new data on experimental medicine
6sources
6articles
4velocity
+31%since first seen
1h agofirst detected
Velocity timeline
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Coverage (6)
- Biggest stock movers Tuesday: Crypto stocks, FCEL, ABVX, and more Seeking Alpha · 8h ago
- Abivax’s ulcerative colitis drug shows benefit in hard-to-treat patients Stock Titan · 8h ago
- Abivax stock surges on obefazimod safety data, cancer concerns qz.com · 8h ago
- Abivax seeks to ease safety concerns with new data, boosting shares statnews.com · 8h ago
- ABVX Stock Rockets 28% After Abivax Eases Drug Safety Concerns With Fresh Clinical Data Yahoo Finance · 8h ago
- French biotech stock soars 34% after new data on experimental medicine CNBC · 8h ago broke it first
Related trends
▲ Peaking
Business
Elon Musk Attacked MacKenzie Scott’s $26 Billion Giving Strategy—but the Data Tells a Completely Different Story
▲ Peaking
Business
iPhone 18 Pro ‘drop test’ leaks get yanked from X
▲ Peaking
Business
EXCLUSIVE: US House committee opens investigation into Merck, AbbVie China drug trials
A US House committee has launched an investigation into drug trials conducted in China by major pharmaceutical companies, including Merck and AbbVie.
▲ Peaking
Business
Ford to recall over 741,000 US vehicles due to park system issue, NHTSA says
Ford is recalling over 741,000 US vehicles after a park system defect was found to potentially cause rollaways.
▲ Peaking
Business
Gold heads for worst quarter in more than a decade as retail frenzy fades
Gold is tracking toward its steepest quarterly decline since 2013 as retail demand cools and investors anticipate Federal Reserve rate hikes.
▲ Peaking
Business